Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

PYXS

Pyxis Oncology, Inc.

CIK 0001782223 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$3.08
↓ 0.04 (-1.28%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Technicals; Risks: Fundamentals, Ownership

Key stats

Market Cap
$195.13M
P/E Ratio
-2.20
EPS
-1.28
Dividend Yield
Not covered
52W Position
45%
Beta
1.18

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
17.06
P/S
Not covered
EV/Revenue
Not covered
ROE
-775.6%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 45%
$1.03$5.55

Latest Financials

2025-12-31 FY
Revenue
$13.86M
Net Income
-$79.62M
Total Assets
$91.52M
Free Cash Flow
-$63.51M

Recent news